Home » Topics » Regulatory » Patents

Patents
RSS

Antibacterial agents disclosed by Hokuriku

Sep. 13, 1996

Allergan discloses compounds with retinoid-like activity

Sep. 13, 1996

Liarozole claimed for inhibiting calcitriol metabolism

Sep. 13, 1996

Retinoid compounds for dermatological disorders

Sep. 13, 1996

Controlled-release oral analgesic formulation claimed by Euroceltique

Sep. 13, 1996

Chiron describes a new opiate receptor ligand

Sep. 13, 1996

Delta-opioid agonists for pain

Sep. 13, 1996

NK1 antagonists from Glaxo Wellcome

Sep. 13, 1996

Meiji Seika discloses natural progesterone antagonists

Sep. 6, 1996

AGE-specific monoclonal antibody from Alteon

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...